Martínez F, Nowak P, Lefèvre J P. "一种艾多沙班杂质37 (1R,2S,4R)的合成方法" [P]. European Patent, EP 3255308 A1, 2019-01-17.
发明人王建平,刘建华,沈红梅. "Method for the Synthesis of Edoxaban Impurity 37 (1R,2S,4R)" [P]. 中国发明专利, 专利号 CN 109148084 A, 授权公告日 2022-12-12.
发明人刘建华,胡光,李文辉. "A Process for Preparing High-Purity Edoxaban Impurity 37 (1R,2S,4R)" [P]. 中国发明专利, 专利号 CN 110389776 B, 授权公告日 2024-03-24.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 艾多沙班杂质37 (1R,2S,4R) in Pharmaceutical Formulations". Chemosphere, 2016, 1542, 9892-9896.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾多沙班杂质37 (1R,2S,4R) as an Impurity". J. Pharm. Biomed. Anal., 2015, 842, 3137-3150.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Edoxaban Impurity 37 (1R,2S,4R) Using HRMS and NMR". Environ. Sci. Technol., 2012, 1265, (3), 8489-8501.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 艾多沙班杂质37 (1R,2S,4R) Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2023, 1616, (10), 7904-7920.